Cigna Investments’s Salesforce CRM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.18M | Sell |
7,524
-1,186
| -14% | -$209K | 0.15% | 108 |
|
|
2026
Q1 | $1.63M | Sell |
8,710
-335
| -4% | -$69.4K | 0.25% | 72 |
|
|
2025
Q4 | $2.4M | Sell |
9,045
-73
| -0.8% | -$18.1K | 0.35% | 45 |
|
|
2025
Q3 | $2.16M | Sell |
9,118
-88
| -1% | -$22.2K | 0.3% | 45 |
|
|
2025
Q2 | $2.51M | Sell |
9,206
-124
| -1% | -$33.2K | 0.43% | 38 |
|
|
2025
Q1 | $2.5M | Sell |
9,330
-206
| -2% | -$64.1K | 0.47% | 30 |
|
|
2024
Q4 | $3.19M | Sell |
9,536
-185
| -2% | -$59K | 0.56% | 26 |
|
|
2024
Q3 | $2.66M | Sell |
9,721
-118
| -1% | -$30.2K | 0.47% | 32 |
|
|
2024
Q2 | $2.53M | Sell |
9,839
-143
| -1% | -$38.3K | 0.47% | 33 |
|
|
2024
Q1 | $3.01M | Sell |
9,982
-169
| -2% | -$48.8K | 0.57% | 26 |
|
|
2023
Q4 | $2.67M | Sell |
10,151
-47
| -0.5% | -$10.6K | 0.55% | 27 |
|
|
2023
Q3 | $2.07M | Sell |
10,198
-1,396
| -12% | -$302K | 0.47% | 34 |
|
|
2023
Q2 | $2.45M | Sell |
11,594
-219
| -2% | -$44.7K | 0.45% | 37 |
|
|
2023
Q1 | $2.36M | Sell |
11,813
-219
| -2% | -$37K | 0.47% | 38 |
|
|
2022
Q4 | $1.6M | Buy |
12,032
+29
| +0.2% | +$4.23K | 0.33% | 58 |
|
|
2022
Q3 | $1.73M | Sell |
12,003
-556
| -4% | -$94.3K | 0.38% | 48 |
|
|
2022
Q2 | $2.07M | Sell |
12,559
-4,427
| -26% | -$782K | 0.41% | 47 |
|
|
2022
Q1 | $3.61M | Sell |
16,986
-4,998
| -23% | -$1.08M | 0.44% | 44 |
|
|
2021
Q4 | $5.59M | Sell |
21,984
-7,623
| -26% | -$2.14M | 0.44% | 37 |
|
|
2021
Q3 | $8.03M | Buy |
29,607
+886
| +3% | +$225K | 0.6% | 25 |
|
|
2021
Q2 | $7.02M | Sell |
28,721
-4,097
| -12% | -$944K | 0.5% | 31 |
|
|
2021
Q1 | $6.95M | Buy |
32,818
+1,115
| +4% | +$248K | 0.48% | 39 |
|
|
2020
Q4 | $7.05M | Buy |
31,703
+2,793
| +10% | +$679K | 0.54% | 34 |
|
|
2020
Q3 | $7.26M | Sell |
28,910
-3,822
| -12% | -$837K | 0.7% | 22 |
|
|
2020
Q2 | $6.13M | Buy |
32,732
+6,793
| +26% | +$1.14M | 0.58% | 32 |
|
|
2020
Q1 | $3.73M | Buy |
25,939
+2,912
| +13% | +$499K | 0.48% | 40 |
|
|
2019
Q4 | $4.2M | Sell |
23,027
-6,289
| -21% | -$986K | 0.44% | 40 |
|
|
2019
Q3 | $4.59M | Buy |
29,316
+4,460
| +18% | +$678K | 0.47% | 36 |
|
|
2019
Q2 | $3.84M | Sell |
24,856
-620
| -2% | -$97.2K | 0.42% | 44 |
|
|
2019
Q1 | $4.04M | Buy |
25,476
+105
| +0.4% | +$16.3K | 0.45% | 38 |
|
|
2018
Q4 | $3.48M | Buy |
25,371
+378
| +2% | +$52K | 0.29% | 46 |
|
|
2018
Q3 | $3.43M | Sell |
24,993
-1,562
| -6% | -$232K | 0.28% | 50 |
|
|
2018
Q2 | $3.62M | Sell |
26,555
-2,635
| -9% | -$336K | 0.26% | 53 |
|
|
2018
Q1 | $3.4M | Sell |
29,190
-46
| -0.2% | -$5.28K | 0.23% | 62 |
|
|
2017
Q4 | $2.99M | Sell |
29,236
-952
| -3% | -$97K | 0.2% | 76 |
|
|
2017
Q3 | $2.82M | Buy |
30,188
+174
| +0.6% | +$16K | 0.19% | 76 |
|
|
2017
Q2 | $2.6M | Buy |
30,014
+3,150
| +12% | +$274K | 0.18% | 83 |
|
|
2017
Q1 | $2.22M | Buy |
26,864
+3,273
| +14% | +$261K | 0.15% | 103 |
|
|
2016
Q4 | $1.61M | Buy |
+23,591
| New | +$1.71M | 0.18% | 129 |
|
Other funds holding CRM
Cigna Investments's CRM Position: Q2 2026 in Review
Cigna Investments reduced its Salesforce (CRM) stake by 14% in Q2 2026, selling an estimated $209K and leaving 7,524 shares worth $1.18M. The position accounts for 0.15% of the portfolio, ranked #108.
Cigna Investments first reported a position in CRM in Q4 2016 and has held it in 39 quarters since. The position peaked at $8.03M in Q3 2021. 2,472 funds tracked by Wall St. Rank hold CRM as of Q2 2026.
- Cigna Investments held 7,524 shares of Salesforce worth $1.18M as of Q2 2026.
- Cigna Investments sold 1,186 Salesforce shares in Q2 2026, an estimated $209K.
- Salesforce made up 0.15% of Cigna Investments's portfolio in Q2 2026, its #108 holding.
- Cigna Investments first reported a position in Salesforce in Q4 2016 and has held it in 39 quarters since.
- Cigna Investments's Salesforce position peaked at $8.03M in Q3 2021.
- 2,472 funds tracked by Wall St. Rank held Salesforce as of Q2 2026.
Based on Cigna Investments's 13F filing for Q2 2026, filed 21 Jul 2026.